First Washington Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.2M Sell
8,516
-86
-1% -$87.9K 2.49% 11
2026
Q1
$7.91M Sell
8,602
-25
-0.3% -$25.3K 2.24% 14
2025
Q4
$9.27M Sell
8,627
-77
-0.9% -$73.6K 2.4% 9
2025
Q3
$6.64M Sell
8,704
-16
-0.2% -$11.9K 1.78% 21
2025
Q2
$6.8M Hold
8,720
2.19% 14
2025
Q1
$7.2M Buy
8,720
+1,487
+21% +$1.24M 2.53% 7
2024
Q4
$5.58M Buy
+7,233
New +$5.99M 1.97% 17

Other funds holding LLY

First Washington Corp's LLY Position: Q2 2026 in Review

First Washington Corp reduced its Eli Lilly (LLY) stake by 1% in Q2 2026, selling an estimated $87.9K and leaving 8,516 shares worth $10.2M. The position accounts for 2.49% of the portfolio, ranked #11.

First Washington Corp first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • First Washington Corp held 8,516 shares of Eli Lilly worth $10.2M as of Q2 2026.
  • First Washington Corp sold 86 Eli Lilly shares in Q2 2026, an estimated $87.9K.
  • Eli Lilly made up 2.49% of First Washington Corp's portfolio in Q2 2026, its #11 holding.
  • First Washington Corp first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on First Washington Corp's 13F filing for Q2 2026, filed 13 Aug 2026.